Skip to main content
Journal ArticleOPEN ACCESS

Clinical and economic impact of implementing OVIVA criteria on patients with bone and joint infections in outpatient parenteral antimicrobial therapy

Clinical Infectious Diseases (2020) 71(1) 207-210
DOI: 10.1093/cid/ciz991
25Citations
Citations of this article
25Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

The OVIVA study demonstrated noninferiority for managing bone and joint infections (BJIs) with oral antibiotics. We report that 79.7% of OPAT patients being treated for BJIs at our center would be eligible for oral antibiotics, saving a median (IQR) 19.5 IV-antibiotic days (8.5-37) and GBP 1234 (569-2594) per patient.

Author supplied keywords

Cite

CITATION STYLE

APA

Marks, M., Bell, L. C. K., Jones, I., Rampling, T., Kranzer, K., Morris-Jones, S., … Pollara, G. (2020). Clinical and economic impact of implementing OVIVA criteria on patients with bone and joint infections in outpatient parenteral antimicrobial therapy. Clinical Infectious Diseases, 71(1), 207–210. https://doi.org/10.1093/cid/ciz991

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free